Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

BUY
$29.6 - $36.56 $34,543 - $42,665
1,167 Added 10.77%
12,001 $368,000
Q1 2023

May 01, 2023

SELL
$32.77 - $39.4 $160,376 - $192,823
-4,894 Reduced 31.12%
10,834 $390,000
Q4 2022

Feb 06, 2023

SELL
$39.17 - $44.04 $29,534 - $33,206
-754 Reduced 4.57%
15,728 $0
Q3 2022

Nov 10, 2022

BUY
$39.88 - $44.65 $657,302 - $735,921
16,482 New
16,482 $662 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.